Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in PBM held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Parallel Advisors, LLC | 151K | $575K | 0.0% | 2.321% | 0.01% |
| 2 | Stonehage Fleming Financial Services Holdings Ltd | 89 | $218 | -84.1% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in PBM — a direct measure of their conviction.
Filings activity in PBM during Q1 2026, grouped by how each filer changed its position.
No new institutional buyers in this quarter.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 2 | 60% | 2.65% | 0.53 pp | $1M | 17% |
| Q4 2025 | 5 | 17% | 3.18% | 0.19 pp | $1M | 5.5% |
| Q3 2025 | 6 | 14% | 3.37% | +0.49 pp | $1M | +17% |
| Q2 2025 | 7 | 22% | 2.88% | +1.72 pp | $1M | +149% |
| Q1 2025 | 9 | 25% | 1.16% | 5.52 pp | $0M | 83% |
| Q4 2024 | 12 | 7.7% | 6.68% | +5.76 pp | $1M | +629% |
| Q3 2024 | 13 | +18% | 0.92% | 0.30 pp | $0M | 25% |
| Q2 2024 | 11 | — | 1.22% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying PBM stock.
Based on Q1 2026 13F filings, institutional ownership of Psyence Biomedical Ltd. stands at 2.6%, held across 2 reporting institutions.
Parallel Advisors, LLC is the largest reported institutional holder of PBM, with approximately 151,250 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of PBM.
Our composite Smart Money Score for PBM is 13 out of 100 (Heavy Distribution). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
0 institutions opened new positions in PBM during Q1 2026, while 3 fully exited. 0 added to existing positions and 2 trimmed.
PBM institutional ownership fell by 0.53 percentage points quarter-over-quarter, with a net change of -3 holders.
The top 10 institutions account for 100.0% of all reported 13F value in PBM, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Psyence Biomedical Ltd. (PBM) Institutional Ownership